Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
427.80    -1.20 (-0.28%)
Bid:
427.60
Ask:
427.80
Spread: 0.20 (0.047%)
Market Cap: £10.76b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Pre stabilisation notice - Rentokil Initial Plc

20 Jun 2022 09:12

RNS Number : 4527P
ING Bank N.V. London Branch
20 June 2022
 

Pré - Stabilisation Notice

ING Bank N.V. (contact: Kris Devos; telephone: 0032 2 557 16 01) hereby gives notice that the Stabilising Manager named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The securities:

Issuer:

Rentokil Initial Plc

Guarantor (if any):

N/A

Aggregate nominal amount:

N/A

Description:

GBP 10yr

Offer price:

Stabilisation:

Stabilising Manager:

ING Groep

Stabilisation period expected to start on:

20/06/2022

Stabilisation period expected to end no later than:

30 days after the proposed issue date of the securities.

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilising Manager may over-allot the securities to the extent permitted in accordance with applicable law.

 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom10.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented

 

Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SSDGZGZVRGRGZZG
Date   Source Headline
30th Jan 20074:48 pmRNSHolding(s) in Company
25th Jan 200711:52 amRNSAnnual Calendar 2007
15th Jan 20073:00 pmRNSMerger Update
11th Jan 20075:10 pmRNSAcquisition
11th Jan 20071:36 pmRNSHolding(s) in Company
2nd Jan 20078:47 amRNSAcquisition
22nd Dec 20069:23 amRNSAcquisition
21st Dec 20061:01 pmRNSDirector/PDMR Shareholding
20th Dec 20061:18 pmRNSTotal Voting Rights
20th Dec 200611:08 amRNSDirector/PDMR Shareholding
18th Dec 20067:09 amRNSAcquisition
11th Dec 200611:30 amRNSHolding(s) in Company
7th Dec 200610:44 amRNSDirector/PDMR Shareholding
30th Nov 20067:04 amRNSReview Electronic Security
30th Nov 20067:01 amRNSAcquisition
24th Nov 20062:37 pmRNSHolding(s) in Company
24th Nov 20062:36 pmRNSHolding(s) in Company
10th Nov 200612:34 pmRNSClarification - Q3 Update
9th Nov 20065:07 pmRNSHolding(s) in Company
9th Nov 20069:57 amRNSInvestor Day
8th Nov 20067:01 amRNS3rd Quarter Results
3rd Nov 20068:00 amRNSFrance - Regulatory Inquiry
30th Oct 20065:45 pmRNSHolding(s) in Company
25th Oct 20063:34 pmRNSAcquisition
18th Oct 20065:15 pmRNSHolding(s) in Company
10th Oct 20062:33 pmRNSBank Facilities
25th Sep 20063:20 pmRNSReporting Timetable
24th Aug 20067:00 amRNSInterim Results
11th Aug 20062:39 pmRNSHolding(s) in Company
21st Jul 20069:12 amRNSDisposal
14th Jul 20062:34 pmRNSDirector Declaration
5th Jul 200611:37 amRNSAnnual Information Update
3rd Jul 20064:45 pmRNSHolding(s) in Company
30th Jun 20067:03 amRNSAcquisition
12th Jun 20065:12 pmRNSHolding(s) in Company
12th Jun 20068:09 amRNSDisposal
5th Jun 20065:03 pmRNSHolding(s) in Company
1st Jun 20064:59 pmRNSDirector/PDMR Shareholding
22nd May 20065:20 pmRNSHolding(s) in Company
22nd May 20065:18 pmRNSHolding(s) in Company
17th May 20064:40 pmRNSDirectorate Change
16th May 20062:43 pmRNSHolding(s) in Company
4th May 20067:01 amRNSTrading Statement
6th Apr 200610:42 amRNSDirector/PDMR Shareholding
6th Apr 200610:42 amRNSDirector/PDMR Shareholding
31st Mar 200612:36 pmRNSEMTN Programme
10th Mar 20062:14 pmRNSDisposal
10th Mar 20061:23 pmRNSHolding(s) in Company
8th Mar 200612:45 pmRNSPublication of Prospectus
7th Mar 20061:46 pmRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.